S. Stick (Perth, Australia), F. Ratjen (Toronto, Canada)
Evaluation of high resolution microscopy for rapid diagnosis of infection in BAL fluid from children with cystic fibrosis F. H. Green, M. Montgomery, C. Mody, E. French (Calgary, Canada)
| |
Clinical status and follow-up of first Pandoraea isolation in the lower airways of paediatric patients with CF M. Ballmann, S. Junge, B. Balke, P. Vandamme, N. Hoiby (Hannover, Germany; Ghent, Belgium; Copenhagen, Denmark)
| |
Biofilm production and adherence to airway epithelial cells of P. aeruginosa strains: effect of N-acetyl-cysteine V. Sorbello, D. Savoia, V. De Rose (Turin, Italy)
| |
8.1 ancestral haplotype (AH) protects against colonization in cystic fibrosis (CF) J. Laki, K. Nemeth, I. Laki, R. Ujhelyi, O. Bede, E. Endreffy, K. Gyurkovits, K. Bolbas, E. Solyom, E. Csiszer, A. Halasz, G. Dobra, I. Karadi, L. Romics, G. Fekete, G. Fust (Budapest, Hungary)
| |
Association of IL-8 A-251T polymorphism with Pseudomonas aeruginosa infection and lung function decline in children with CF I. A. Laing, A. C. Martin, M. L. Cox, S. K. Khoo, J. Goldblatt, P. N. Le Souef (Perth, Australia)
| |
Interleukin-6 gene variants are associated with early Pseudomonas infection in cystic fibrosis N. Knauer, J. Brouard, H. Corvol, A. Henrion-Caude, P. Y. Boelle, C. Flamant, K. Chadelat, M. C. Miesch, F. Ratjen, H. Grasemann, A. Clément (Paris, France; Essen, Germany)
| |
Correlation analysis of the colonization by Pseudomonas aeruginosa and genetic polymorphism of nitric oxide synthases in patients with cystic fibrosis N. A. Kelembet, T. E. Ivaschenko, T. E. Gembitskaya (St. Petersburg, Russian Federation)
| |
Safety of endobronchial biopsy in children with cystic fibrosis A. Molina-Teran, T. N. Hilliard, S. Saglani, E. Haxby, A. Bush, J. C. Davies (London, United Kingdom)
| |
Mannose-binding lectin 2 in cystic fibrosis S. Crovella, C. Trevisiol, F. Poli, I. Giuseppin (Trieste, Italy)
| |
8-iso Prostaglandin F2a and sCD163 in bronchoalveolar lavage fluid of patients with cystic fibrosis under therapy with recombinant DNAse M. Timmermann, E. Rietschel, K. Paul, P. Högger (Würzburg, Köln, Germany)
| |
Confirmation by FRET of Ca2+-mediated NF-kB activation in individual cystic fibrosis airway epithelial cells O. Tabary, E. Boncoeur, R. De Martin, A. Clément, R. Pepperkok, C. Schultz, J. Jacquot (Paris, France; Vienna, Austria; Heidelberg, Germany)
| |
Parameters of oxidative stress in exhaled breath condensate are more pronounced in females then in males with cystic fibrosis L. Fila, J. Musil, J. Chládek (Prague, Hradec Králové, Czech Republic)
| |
Change in FEV0.5: FVC in healthy children and those with cystic fibrosis (CF) from infancy to the preschool years W. Kozlowska, C. Saunders, S. Lum, P. Aurora, S. Ranganthan, A. Bush, J. Stocks (London, United Kingdom)
| |
Increased respiratory resistance using forced oscillations in symptomatic young children with cystic fibrosis C. L. Gangell, G. L. Hall, S. Brennan, H. J. Patterson, K. Udomittipong, P. D. Sly, S. M. Stick (Perth, Australia)
| |
Correlation between radiologic and functional status in stable cystic fibrosis M. V. Kakoura, A. Morichovitou, D. Chloros, G. Tsiaousis, M. Fotoulaki, C. H. Tsantiridis, E. Fouka, J. Tsitouridis (Thessaloniki, Greece)
| |
Changes in quantitative measures of airways on computed tomography (CT) in children with cystic fibrosis (CF) P. A. de Jong, Y. Nakano, W. C. J. Hop, F. R. Long, H. O. Coxson, P. D. Paré, H. A. Tiddens (Rotterdam, Netherlands; Columbus, United States Of America; Vancouver, Canada)
| |
Cystic fibrosis related pulmonary disease: more structure than function? L. Rubin, P. A. De Jong, M. H. Lequin, W. C. Hop, B. Assael, H. A. Tiddens (Verona, Italy; Rotterdam, Netherlands)
| |
Longitudinal changes on high-resolution CT in adults with cystic fibrosis: comparison with spirometry E. P. Judge, J. D. Dodd, J. B. Masterson, C. G. Gallagher (Dublin, Ireland)
| |
Intrapulmonal deposition of two different tobramycin formulations S. Haeussermann, P. Brand, A. Fischer, T. Meyer, B. Muellinger, J. Seitz, K. Sommerer, J. Stegemann, B. Wachall, G. Scheuch (Gauting, Gemuenden, Heppenheim, Germany)
| |
Clinical pharmacology study of a new tobramycin solution for nebulisation G. Poli, D. Acerbi, R. Pennini, A. Soliani Raschini, M. Corrado, H. G. Eichler, I. Eichler (Parma, Italy; Arzo, Switzerland; Vienna, Austria)
| |